The agreement represents the single largest order to date for
Rejuvel’s breakthrough skin renewal cream
Rejuvel
Bio-Sciences, Inc. (OTCQB: NUUU), a NASA Technology Transfer Partner
and creator of REJUVEL
3D Ageless Infinity Microgravity Cell Renewal Cream, announced today
that its wholly-owned subsidiary, Rejuvel Int'l, Inc., has signed a new
distribution agreement with the Houboubati Group of Companies, based in
the United Arab Emirates.
This Smart News Release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20150811005167/en/
Dermatologists, facial experts and wellness center clients who have tried the product report amazing results. Wrinkles diminish. Dark blotches and nasty scars fade. And dry flaky skin becomes moist and smooth. (Photo: Business Wire)
The agreement will make REJUVEL 3D skin cream available in Saudi Arabia,
Qatar, Kuwait and the United Arab Emirates.
“This agreement is a major step in our strategy of reaching customers
around the world and building a global brand,” said Charles
Scimeca, President of Rejuvel Bio-Sciences. “We also expect REJUVEL
3D to be especially successful in the dry and arid climate of the Middle
East because of its ability to increase skin moisturization.”
The key ingredient in REJUVEL 3D is made by stem cells from a type of
green tea plant, Camellia sinensis, that are grown in a special
bioreactor developed by NASA engineers that mimics the microgravity
conditions of space. Because cells grow differently in microgravity,
they make far more of the
healing substances that are known to exist in green tea extract —
and they may make more potent substances as well.
Dermatologists, facial experts and wellness center clients who have
tried the product report
amazing results. Wrinkles diminish. Dark blotches and nasty scars
fade. And dry flaky skin becomes moist and smooth.
“We’re pleased that the Houboubati Group of Companies has recognized
that our product offers major advantages over competitors, thanks to the
unique science behind REJUVEL 3D,” said Scimeca.
This agreement includes an initial order of $71,250. That represents the
largest single order to date for the product and underscores the
transition that Rejuvel Bio-Sciences, Inc. has made from a developmental
stage company to a company with growing revenues.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150811005167/en/
Copyright Business Wire 2015